T-helper 17 (Th17) cells play an important role in the pathogenesis of multiple sclerosis (MS), an autoimmune demyelinating disease that affects the CNS. In the present study, MicroRNA sequencing (miRNA-seq) was performed in mouse Th0 and Th17 cells to determine the critical miRNAs that are related to Th17 differentiation. We found that miR-30a was significantly downregulated during mouse Th17 differentiation. In addition, the level of miR-30a in CD4 ϩ T cells from peripheral blood of MS patients and experimental autoimmune encephalomyelitis (EAE) animal models was also decreased and inversely correlated with the expression of interleukin 17a, the canonical cytokine of Th17 cells. Moreover, overexpression of miR-30a inhibited Th17 differentiation and prevented the full development of EAE, whereas interference of miR-30a promoted Th17 differentiation. Mechanism studies showed that miR-30a reduced IRF4 expression by specifically binding with the 3Ј-untranslated region. Through screening of 640 different Food and Drug Administration (FDA)-approved drugs, we found that disulfiram and diphenhydramine hydrochloride were effective candidates for inhibiting Th17 differentiation and ameliorating EAE development through upregulating miR-30a. To our knowledge, the present work is not only the first miRNA-seq study focusing on Th17 differentiation, but also the first chemical screening for FDA-approved drugs that inhibit Th17 differentiation through regulating miRNA expression.
ObjectiveTo investigate levels of regulatory B (Breg) cells, plasma cells, and memory
B cells in the peripheral blood, and interleukin (IL)-10 in the serum of
multiple sclerosis (MS) patients, and to determine the correlation between
Breg cell levels and the Expanded Disability Status Scale (EDSS) score.MethodsLevels of Breg cells, plasma cells, and memory B cells in the peripheral
blood of 12 MS patients were measured using flow cytometry. IL-10 serum
levels were measured by enzyme-linked immunosorbent assay. The correlation
between Breg cell levels and MS EDSS score was measured using Pearson’s
correlation coefficient.ResultsCompared with healthy controls, MS patients had decreased levels of
CD19+CD24hiCD38hi Breg cells in their
peripheral blood and reduced serum levels of IL-10; however, the ratios of
CD19+CD27hiCD38hi plasma cells and
CD19+CD27+CD24hi memory B cells to
total B cells did not differ significantly between healthy controls and MS
patients. CD19+CD24hiCD38hi Breg cell
levels in the peripheral blood of MS patients were not significantly
correlated with MS EDSS score.ConclusionPeripheral blood CD19+CD24hiCD38hi Breg cell
levels and serum IL-10 levels were reduced in MS patients compared with
controls, but Breg cell levels were not correlated with MS EDSS score.
ABSTRACT.A variety of anti-neuronal cell membrane antibodies such as voltage-gated potassium channel antibody, N-methyl-Daspartate-2B-antibody, and glutamic acid decarboxylase antibody, are correlated with limbic encephalitis (LE). In this study on patients with LE, the clinical manifestations, psychology Wechsler Adult Intelligence Scale, cerebrospinal fluid, electrophysiology, magnetic resonance imaging, and anti-immune therapy were studied and immunological determination was conducted; it was found that patients of Chinese Han nationality showed 2 types of clinical manifestations: simple and complex. Lesions could also be divided into focal and scalable lesions, and the clinical manifestations and lesions scopes were associated with various antibodies and antibody types. The prognosis may improve if early diagnosis is conducted and early anti-immune therapy is implemented in LE patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.